These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

344 related articles for article (PubMed ID: 34019142)

  • 41. Influence of human immunodeficiency virus infection on cell-mediated immunity in chronic D hepatitis.
    Buti M; Esteban R; Español MT; Malagelada A; Jardi R; Rodriguez-Frias F; Roget M; Guardia J
    J Infect Dis; 1991 Jun; 163(6):1351-3. PubMed ID: 1674749
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Inhibitory Effect of IL-1β on HBV and HDV Replication and HBs Antigen-Dependent Modulation of Its Secretion by Macrophages.
    Delphin M; Faure-Dupuy S; Isorce N; Rivoire M; Salvetti A; Durantel D; Lucifora J
    Viruses; 2021 Dec; 14(1):. PubMed ID: 35062269
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Hepatitis delta virus (HDV) infection and disease.
    Rizzetto M
    Ric Clin Lab; 1989; 19(1):11-26. PubMed ID: 2669109
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Assembly and infection efficacy of hepatitis B virus surface protein exchanges in 8 hepatitis D virus genotype isolates.
    Wang W; Lempp FA; Schlund F; Walter L; Decker CC; Zhang Z; Ni Y; Urban S
    J Hepatol; 2021 Aug; 75(2):311-323. PubMed ID: 33845061
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Entry Inhibitors of Hepatitis B and D Viruses.
    Yang Y; Xie Y
    Adv Exp Med Biol; 2022; 1366():199-205. PubMed ID: 35412142
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Infection by Hepatitis Delta Virus.
    Taylor JM
    Viruses; 2020 Jun; 12(6):. PubMed ID: 32560053
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Recognizing the impact of endemic hepatitis D virus on hepatitis B virus eradication.
    Goyal A; Murray JM
    Theor Popul Biol; 2016 Dec; 112():60-69. PubMed ID: 27594346
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Human CD4+ T-cell response to hepatitis delta virus: identification of multiple epitopes and characterization of T-helper cytokine profiles.
    Nisini R; Paroli M; Accapezzato D; Bonino F; Rosina F; Santantonio T; Sallusto F; Amoroso A; Houghton M; Barnaba V
    J Virol; 1997 Mar; 71(3):2241-51. PubMed ID: 9032359
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Persistence of hepatitis B virus and establishment of delta virus infection.
    Nordenfelt E
    Scand J Infect Dis Suppl; 1990; 69():121-4. PubMed ID: 2263889
    [TBL] [Abstract][Full Text] [Related]  

  • 50. HDV Pathogenesis: Unravelling Ariadne's Thread.
    Tseligka ED; Clément S; Negro F
    Viruses; 2021 Apr; 13(5):. PubMed ID: 33924806
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Predominance of HBV Genotype B and HDV Genotype 1 in Vietnamese Patients with Chronic Hepatitis.
    Hoan NX; Hoechel M; Tomazatos A; Anh CX; Pallerla SR; Linh LTK; Binh MT; Sy BT; Toan NL; Wedemeyer H; Bock CT; Kremsner PG; Meyer CG; Song LH; Velavan TP
    Viruses; 2021 Feb; 13(2):. PubMed ID: 33671832
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Clinical course and outcomes of chronic viral hepatitis D in patients from Republic of Tuva as endemic region].
    Isaeva OV; Il'chenko LY; Saryglar AA; Karlsen AA; Kyuregyan KK; Mikhailov MI
    Vopr Virusol; 2021 Mar; 66(1):74-83. PubMed ID: 33683068
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Strategies for the treatment of HBV/HDV.
    Krause A; Haberkorn U; Mier W
    Eur J Pharmacol; 2018 Aug; 833():379-391. PubMed ID: 29935174
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Virus entry and its inhibition to prevent and treat hepatitis B and hepatitis D virus infections.
    Tu T; Urban S
    Curr Opin Virol; 2018 Jun; 30():68-79. PubMed ID: 29775812
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Hepatocyte Intrinsic Innate Antiviral Immunity against Hepatitis Delta Virus Infection: The Voices of Bona Fide Human Hepatocytes.
    Woo Y; Ma M; Okawa M; Saito T
    Viruses; 2024 May; 16(5):. PubMed ID: 38793622
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Co-expression of markers for hepatitis delta and hepatitis B viruses in human liver.
    Ryley NG; Heryet AR; Goldin R; Monjardino J; Saldanha J; Fleming KA
    Histopathology; 1992 Apr; 20(4):331-7. PubMed ID: 1577410
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Snake Deltavirus Utilizes Envelope Proteins of Different Viruses To Generate Infectious Particles.
    Szirovicza L; Hetzel U; Kipar A; Martinez-Sobrido L; Vapalahti O; Hepojoki J
    mBio; 2020 Mar; 11(2):. PubMed ID: 32184255
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Envelope proteins derived from naturally integrated hepatitis B virus DNA support assembly and release of infectious hepatitis delta virus particles.
    Freitas N; Cunha C; Menne S; Gudima SO
    J Virol; 2014 May; 88(10):5742-54. PubMed ID: 24623409
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Coinfection of hepatitis B and hepatitis delta virus in Belgium: a multicenter BASL study. Prospective epidemiology and comparison with HBV mono-infection.
    Ho E; Deltenre P; Nkuize M; Delwaide J; Colle I; Michielsen P;
    J Med Virol; 2013 Sep; 85(9):1513-7. PubMed ID: 23852675
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Clinical effects of NTCP-inhibitor myrcludex B.
    Cheng D; Han B; Zhang W; Wu W
    J Viral Hepat; 2021 Jun; 28(6):852-858. PubMed ID: 33599010
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.